Synergism between the CD3 antigen-and CD2 antigen-derived signals

Exploration at the level of induction of dna-binding proteins and characterization of the inhibitory activity of cyclosporine

P. K. Sehajpal, V. K. Sharma, E. Ingulli, K. H. Stenzel, Manikkam Suthanthiran

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

We have demonstrated earlier that the crosslinkage of the CD3/TCR complex with the CD2 antigen results in the proliferation of normal human T cells. The effect of this synergism was perceptible at the level of induction of the IL-2 gene, a process critical for T cell growth. To further understand the molecular and nuclear basis for this synergism, we have explored the induction of DNA-binding proteins in highly purified normal human T cells signaled via the CD3 and/or CD2 proteins. The effect of transmembrane signaling of T cells with ionomycin, and/or sn-1, 2 dioctanoyl glycerol, was also determined. The emergence of nuclear binding proteins was investigated using interleukin-2 sequence specific oligonucleotide probes in the electrophoretic mobility shift assay. Our studies demonstrate for the first time that CD3 antigen-derived signals and CD2 antigen-derived signals are synergistic in inducing the emergence of transcription factors that bind to the NF-AT1, AP-1, and NF-kB sites located in the promoter/enhancer region of the IL-2 gene. Moreover, cyclosporine, at concentrations readily accomplished in clinical practice, was found to inhibit the emergence of these DNA-binding proteins in normal human T cells signaled via cell surface proteins implicated in antigen-dependent T cell activation and in T cells stimulated by mobilization of cellular calcium and activation of protein kinase C.

Original languageEnglish
Pages (from-to)1118-1124
Number of pages7
JournalTransplantation
Volume55
Issue number5
Publication statusPublished - 1 Jan 1993
Externally publishedYes

Fingerprint

CD2 Antigens
CD3 Antigens
Cyclosporine
Carrier Proteins
T-Lymphocytes
Interleukin-2
DNA-Binding Proteins
T-Cell Antigen Receptor-CD3 Complex
CD27 Antigens
Ionomycin
Oligonucleotide Probes
NF-kappa B
Transcription Factor AP-1
Electrophoretic Mobility Shift Assay
Nuclear Proteins
Genetic Promoter Regions
Protein Kinase C
Genes
Membrane Proteins
Transcription Factors

ASJC Scopus subject areas

  • Transplantation

Cite this

Synergism between the CD3 antigen-and CD2 antigen-derived signals : Exploration at the level of induction of dna-binding proteins and characterization of the inhibitory activity of cyclosporine. / Sehajpal, P. K.; Sharma, V. K.; Ingulli, E.; Stenzel, K. H.; Suthanthiran, Manikkam.

In: Transplantation, Vol. 55, No. 5, 01.01.1993, p. 1118-1124.

Research output: Contribution to journalArticle

@article{7a219769e57547e0a342faa88fa92f44,
title = "Synergism between the CD3 antigen-and CD2 antigen-derived signals: Exploration at the level of induction of dna-binding proteins and characterization of the inhibitory activity of cyclosporine",
abstract = "We have demonstrated earlier that the crosslinkage of the CD3/TCR complex with the CD2 antigen results in the proliferation of normal human T cells. The effect of this synergism was perceptible at the level of induction of the IL-2 gene, a process critical for T cell growth. To further understand the molecular and nuclear basis for this synergism, we have explored the induction of DNA-binding proteins in highly purified normal human T cells signaled via the CD3 and/or CD2 proteins. The effect of transmembrane signaling of T cells with ionomycin, and/or sn-1, 2 dioctanoyl glycerol, was also determined. The emergence of nuclear binding proteins was investigated using interleukin-2 sequence specific oligonucleotide probes in the electrophoretic mobility shift assay. Our studies demonstrate for the first time that CD3 antigen-derived signals and CD2 antigen-derived signals are synergistic in inducing the emergence of transcription factors that bind to the NF-AT1, AP-1, and NF-kB sites located in the promoter/enhancer region of the IL-2 gene. Moreover, cyclosporine, at concentrations readily accomplished in clinical practice, was found to inhibit the emergence of these DNA-binding proteins in normal human T cells signaled via cell surface proteins implicated in antigen-dependent T cell activation and in T cells stimulated by mobilization of cellular calcium and activation of protein kinase C.",
author = "Sehajpal, {P. K.} and Sharma, {V. K.} and E. Ingulli and Stenzel, {K. H.} and Manikkam Suthanthiran",
year = "1993",
month = "1",
day = "1",
language = "English",
volume = "55",
pages = "1118--1124",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Synergism between the CD3 antigen-and CD2 antigen-derived signals

T2 - Exploration at the level of induction of dna-binding proteins and characterization of the inhibitory activity of cyclosporine

AU - Sehajpal, P. K.

AU - Sharma, V. K.

AU - Ingulli, E.

AU - Stenzel, K. H.

AU - Suthanthiran, Manikkam

PY - 1993/1/1

Y1 - 1993/1/1

N2 - We have demonstrated earlier that the crosslinkage of the CD3/TCR complex with the CD2 antigen results in the proliferation of normal human T cells. The effect of this synergism was perceptible at the level of induction of the IL-2 gene, a process critical for T cell growth. To further understand the molecular and nuclear basis for this synergism, we have explored the induction of DNA-binding proteins in highly purified normal human T cells signaled via the CD3 and/or CD2 proteins. The effect of transmembrane signaling of T cells with ionomycin, and/or sn-1, 2 dioctanoyl glycerol, was also determined. The emergence of nuclear binding proteins was investigated using interleukin-2 sequence specific oligonucleotide probes in the electrophoretic mobility shift assay. Our studies demonstrate for the first time that CD3 antigen-derived signals and CD2 antigen-derived signals are synergistic in inducing the emergence of transcription factors that bind to the NF-AT1, AP-1, and NF-kB sites located in the promoter/enhancer region of the IL-2 gene. Moreover, cyclosporine, at concentrations readily accomplished in clinical practice, was found to inhibit the emergence of these DNA-binding proteins in normal human T cells signaled via cell surface proteins implicated in antigen-dependent T cell activation and in T cells stimulated by mobilization of cellular calcium and activation of protein kinase C.

AB - We have demonstrated earlier that the crosslinkage of the CD3/TCR complex with the CD2 antigen results in the proliferation of normal human T cells. The effect of this synergism was perceptible at the level of induction of the IL-2 gene, a process critical for T cell growth. To further understand the molecular and nuclear basis for this synergism, we have explored the induction of DNA-binding proteins in highly purified normal human T cells signaled via the CD3 and/or CD2 proteins. The effect of transmembrane signaling of T cells with ionomycin, and/or sn-1, 2 dioctanoyl glycerol, was also determined. The emergence of nuclear binding proteins was investigated using interleukin-2 sequence specific oligonucleotide probes in the electrophoretic mobility shift assay. Our studies demonstrate for the first time that CD3 antigen-derived signals and CD2 antigen-derived signals are synergistic in inducing the emergence of transcription factors that bind to the NF-AT1, AP-1, and NF-kB sites located in the promoter/enhancer region of the IL-2 gene. Moreover, cyclosporine, at concentrations readily accomplished in clinical practice, was found to inhibit the emergence of these DNA-binding proteins in normal human T cells signaled via cell surface proteins implicated in antigen-dependent T cell activation and in T cells stimulated by mobilization of cellular calcium and activation of protein kinase C.

UR - http://www.scopus.com/inward/record.url?scp=0027310887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027310887&partnerID=8YFLogxK

M3 - Article

VL - 55

SP - 1118

EP - 1124

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 5

ER -